Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients

Author(s):
Vollenhoven, R.F. van; Mild, M.; Doria, A.; Dorner, T.; Ferraccioli, G.; Houssiau, F.; Huizinga, T.W.J. (0000-0001-7033-7520); Isenberg, D.A.; Kovacs, L.; Ruiz-Irastorza, G.; Squatrito, D.; Voskuyl, A.; Mosca, M.; Sebastiani, G.D.; Inanc, M.; Szucs, G.; Jacobsen, S.; Castro, A.; IRBIS-EMA Grp
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S684-S684
hdl
1887/98631